Contribution by Frédérique Faivre Petit, Partner, on the “Patentability of Antibodies on Both Sides of the Atlantic: EPO Case Law and the Lessons of Amgen vs. Sanofi” at the conference organized by LES and ASPI on the “2017-2018 IP News on medicine: CCP, competition and case law
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.